PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-25.32%
Negative net income growth while JD stands at 10.51%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
8.57%
D&A growth of 8.57% while JD is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-70.00%
Negative yoy deferred tax while JD stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.11%
Negative yoy SBC while JD is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
61.95%
Working capital change of 61.95% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
64.00%
AR growth of 64.00% while JD is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-594.29%
Negative yoy inventory while JD is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
212.07%
AP growth of 212.07% while JD is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
48.99%
Growth of 48.99% while JD is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-4.03%
Both negative yoy, with JD at -301.39%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
22.19%
Some CFO growth while JD is negative at -173.37%. John Neff would note a short-term liquidity lead over the competitor.
-47.83%
Negative yoy CapEx while JD is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
81.82%
Acquisition growth of 81.82% while JD is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-29.54%
Negative yoy purchasing while JD stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
221.55%
Liquidation growth of 221.55% while JD is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
98.01%
Lower net investing outflow yoy vs. JD's 230.06%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
-719.44%
We cut debt repayment yoy while JD is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-66.67%
Negative yoy issuance while JD is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.